Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC

NCT03995875 · clinicaltrials.gov ↗

COMPLETED

Status

529

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Sponsor

AstraZeneca

Collaborators

[object Object]